Skeletalis

Boston, United States

Skeletalis develops precision medicines targeting bone loss to treat osteoporosis and prevent fractures safely.

$8.0M raised

Nov 2025

Seed

Top Investors

KdT VenturesPillar VCage1Slocum Wealth Management

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Skeletalis raised?

Skeletalis has raised $8.0M in total funding. The most recent round was Seed. The last funding was announced in November 2025.

Who are Skeletalis's investors?

Skeletalis's investors include KdT Ventures, Pillar VC, age1, Slocum Wealth Management.

Where is Skeletalis headquartered?

Skeletalis is headquartered in Boston, United States.

What does Skeletalis do?

Skeletalis develops precision medicines targeting bone loss to treat osteoporosis and prevent fractures safely.

What stage is Skeletalis at?

Skeletalis is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 17, 2025.

MLA

"Skeletalis — Funding & Investors." VCBacked, November 17, 2025, https://www.vcbacked.co/company/skeletalis. Accessed June 3, 2026.

APA

VCBacked. (2025). Skeletalis — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/skeletalis

Wikipedia (cite web)

{{cite web |title=Skeletalis — Funding & Investors |url=https://www.vcbacked.co/company/skeletalis |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 17, 2025.